A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library

Immunotechnology

Volumn 4, Issue 2, 1998, Pages 127-140

  Hall, Brenda L ^a   Boroughs, Jon ^a   Kobrin, Barry J ^a  

^a Intracel Corp   (United States)

Author keywords

Antibody phage display library; Immunohistochemistry; Tumor specific human scFv

Indexed keywords

ANNEXIN; BCG VACCINE; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 28A32; MONOCLONAL ANTIBODY 5 11A; POLYSTYRENE; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COLON TUMOR; DELAYED HYPERSENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; LYMPHOCYTE PROLIFERATION; PHAGE DISPLAY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; BACTERIOPHAGES; CARCINOMA, SQUAMOUS CELL; COLONIC NEOPLASMS; EPITOPES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MICE; PEPTIDE LIBRARY; RECOMBINANT PROTEINS;

EID: 0031791593     PISSN: 13802933     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1380-2933(98)00016-5     Document Type: Article

References (49)

1. Hellstrom KE, Hellstrom I. In: DeVita VT, Hellman S, Rosenberg SA, editors. Biologic Therapy of Cancer: Principles and Practices. 1991:35-52.
2. Khazaeli M.B., Conry R.M., LoBuglio A.F. J Immunother. 15:1994;42-52.
3. Honsono M., Endo K., Sakahara H.et al. Br J Cancer. 65:1992;197-200.
4. Shin S. Biotherapy. 3:1991;43.
5. LoBuglio A.F., Wheeler R.H., Trang J.et al. Proc Natl Acad Sci USA. 86:1989;4220-4224.
6. Carter P., Presta L., Gorman C.M.et al. Proc Natl Acad Sci USA. 89:1992;4285-4289.
7. Queen C., Schneider W.P., Selick H.E.et al. Proc Natl Acad Sci USA. 86:1989;10029-10033.
8. Kashmiri S., Shu L., Padlan E., Milenic D., Schlom J., Hand P. Hybridoma. 14:1995;461-473.
9. Isaacs J.D., Watts R.A., Hazleman B.L.et al. Lancet. 340:1992;748-752.
10. Steis R.G., Carrasquillo J.A., McCabe R.et al. J Clin Oncol. 8:1990;476-490.
11. De Jager R.L., McCabe R.P., Subramanian R.et al. Proc Am Assoc Cancer Res. 32:1991;184.
12. De Jager R., Abdel-Nabi H., Serafini A., Pecking A., Klein J.L., Hanna M.G. Jr. Semin Nucl Med. 23:1993;165-179.
13. Serafini AN, Klein JL, Wolff BG et al. J Clin Oncol 1998;16:1777-87.
14. Glassy M. Hum Antib Hybrid. 4:1993;154-156.
15. Hoover H.C., Surdyke M.G., Dangle R.B., Peters L.C., Hanna M.G. Cancer (Phila). 55:1985;1236-1243.
16. Haspel M.V., McCabe R.P., Pomato N.et al. Cancer Res. 45:1985;3951-3961.
17. Hanna MG Jr, Haspel MV, McCabe RP, Murray JH, Pomato N. In: Antibody, Immunoconjugate, and Radiopharmaceutical. New York: Mary Ann Liebert, 1991:67-75.
18. Murray J.H., Haspel M.V., Hillman E., McCabe R.P., Hanna M.G. Jr. Proc Am Assoc Cancer Res. 32:1991;201.
19. Hall B.L., Murray J.H., Haspel M.V., Kobrin B.J. Cancer Res. 54:1994;5178-5185.
20. Pomato N.A., Ransom J.H., Chin-Carlson M.et al. Vaccine Res. 3:1994;145-161.
21. McCafferty J., Griffiths A.D., Winter G., Chiswell D.J. Nature. 348:1990;552-554.
22. Johnson K., Chiswell D.J. Curr Opin Struct Biol. 3:1993;564-571.
23. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Ann Rev Immunol. 12:1994;433-455.
24. Chomczynski P., Sacchi N. Anal Biochem. 162:1987;156-159.
25. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Grifiths A.D., Winter G. J Mol Biol. 222:1991;581-597.
26. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., Winter G. Nucl Acids Res. 19:1991;4133-4137.
27. Hopp T.P., Prickett K.S., Price V.L.et al. Biotechnology. 6:1988;1204-1210.
28. Hawkins R.E., Russell S.J., Winter G. J Mol Biol. 226:1992;889-896.
29. Pluckthun A., Skerra A. Methods Enzymol. 178:1989;497-515.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. Plainview, New York: Cold Spring Harbor Laboratory Press, 1989.
31. Shulman M., Wilde C.D., Kohler G. Nature. 276:1978;269-270.
32. Janolino V.G.et al. App Biochem Biotech. 56:1996;1-7.
33. Schier R., Bye J., Apell G.et al. J Mol Biol. 255:1996;28-43.
34. Vaughn T.J., Williams A.J., Pritchard K.et al. Nature Biotech. 14:1996;309-314.
35. Djavadi-Ohaniance L, Figuet B. In: Butler LE, editor. The Immunochemistry of Solid-Phase Immunoassay. Boca Raton, FL: CRC Press, 1991:201-6.
36. Scwab C., Bosshard H.R. J Immunol Methods. 147:1992;125-134.
37. Tomlinson IM, et al. V BASE Sequence Directory. Cambridge, UK: MRC Centre for Protein Engineering, 1998.
38. Ohlin M., Owman H., Mach M., Borrebaeck C.A.K. Mol Immunol. 33:1996;47-56.
39. Pomato N, Murray JH, Bos E, Haspel MV, McCabe RP, Hanna MG Jr. In: Metzger RS, Mitchell MS, editors. Human Tumor Antigens and Specific Tumor Therapy. New York: Liss, 1989:127-36.
40. Cai X., Garen A. Proc Natl Acad Sci USA. 92:1995;6537-6541.
41. Cai X., Garen A. Proc Natl Acad Sci USA. 93:1996;6280-6285.
42. Cai X., Garen A. Proc Natl Acad Sci USA. 94:1997;9261-9266.
43. Griffiths A.D., Williams S.C., Hartley O.et al. EMBO J. 13:1994;3245-3260.
44. Hoogenboom H.R., Winter G. J Mol Biol. 227:1992;381-388.
45. Nissim A., Hoogenboom H.R., Tomlinson I.M.et al. EMBO J. 13:1994;692-698.
46. de Kruif J., Boel E., Logtenberg T. J Mol Biol. 248:1995;97-105.
47. Pereira S., Van Belle P., Elder D.et al. Hybridoma. 16:1997;11-16.
48. Siegel D.L., Chang T.Y., Russell S.L., Bunya V.Y. J Immunol Methods. 206:1997;73-85.
49. Pereira S., Maruyama H., Siegal D.et al. J Immunol Methods. 203:1997;11-24.